Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide in prevention of dry socket and pain after tooth extraction
IRCT20230627058604N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of teriparatide in alveolar osteitis (AO) and postoperative pain, sponsored by Tabriz University of Medical Sciences. Primary endpoints: Incidence of dry socket and Postoperative pain. Started Oct 2023; status: completed.
02
Drugs
teriparatide
03
Conditions
alveolar osteitis (AO)postoperative pain
Beyond the preview
Go deeper on IRCT20230627058604N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230627058604N1.